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1. INTRODUCTION 
Vaccinia virus (VACV) belongs to the Poxviridae, which comprise a large family of 
complex DNA viruses. VACV is the prototypic and best characterized member of the 
Orthopoxvirus genus (Condit et al, 2006). VACV was the live vaccine used in the 
vaccination program coordinated by the World Health Organization that lead to the 
eradication of human smallpox in 1977 being the only extinct human infectious 
disease worldwide (Fenner, 1980). Despite the importance of VACV strains as 
vaccines against variola virus, theirs use was associated with a high incidence of 
adverse events after primary vaccination. Therefore, highly attenuated strains of 
VACV were developed to overcome those risks. Modified Vaccinia virus Ankara 
(MVA) was derived from Chorioallantois vaccinia virus Ankara (CVA) by more than 
570 passages in chicken embryofibroblasts cells (CEF) (Mayr & Munz, 1964). MVA 
became replication deficient in almost all mammalian cells, however maintaining 
good immunogenicity. The diminished virulence in mammalian hosts further improves 
the safety of MVA as a vector. Despite the considerable loss of genetic material, 
MVA is still able to efficiently express recombinant genes in infected cells (Mayr et al, 
1978). Thus, MVA is a promising candidate vector for antigen delivery against 
different infectious diseases in animals and humans, including influenza, tuberculosis 
and HIV (Gilbert, 2013). Additionally the importance of MVA-based smallpox vaccine 
has been renewed due to the risk of accidental or intentional release of variola virus 
(Reardon, 2014). MVA no longer encodes many of the immunomodulatory factors 
produced by conventional VACV strains, and as a consequence this leads to rapid 
local immune responses (McFadden, 2005). Yet, how the viruses activate the innate 
immune system remains incompletely understood. For these reasons, yet it is 
desirable to elucidate the molecular immune mechanisms activated upon MVA 
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infection. This better understanding should help to further improve the development 
and rational use of new MVA-based vaccines.  
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2. LITERATURE REVIEW 
2.1 Poxviruses  
2.1.1 Taxonomy of Poxviruses 
Viruses of the Poxviridae family are divided into two subfamilies, Chordopoxvirinae 
and Entomopoxvirinae, based on vertebrate and insect host range respectively. The 
Chordopoxvirinae consists of ten genera: Avipoxvirus, Cervidpoxvirus, 
Crocodylipoxvirus, Capripoxvirus, Leporipoxvirus, Molluscipoxvirus, Orthopoxvirus, 
Parapoxvirus, Suipoxvirus and Yatapoxvirus. Four genera contain species that infect 
humans: Molluscipoxvirus, Orthopoxvirus, Parapoxvirus and Yatapoxvirus (Baxby & 
Bennett, 1997). The members of a same genus possess similar morphology and are 
genetically related (Condit et al, 2006).  
2.1.2 Morphology 
Poxvirus particles are exceptionally large; its size is around 250 nm in diameter and 
360 nm in length, characterized by having a round brick-shape (Fig. 2.1). There are 
two different infectious particles: internal mature virus (IMV) and extracellular 
enveloped virus (EEV), they are structurally similar, however EEV carry an additional 
outer lipid membrane containing proteins absent from IMV(Fig. 2.1) (Locker et al, 
2000).  
Poxviruses virions contain a large single linear double-stranded deoxyribonucleic 
acid (dsDNA) genome of 130-300 kilobase pairs (kb), with termini that form 
covalently closed hairpin loops. Chordopoxvirinae encode between 136 and 260 
open reading frames (ORF) approximately (Schramm & Locker, 2005). Essential 
genes are located in the central region of the genome and are highly conserved 
among poxviruses, while end terminal genes are non-essential for replication, more 
diverse and usually related to immune subversion or host range restriction (Werden 
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et al, 2008). The viral genome is packaged into a biconcave core flanked on two 
sides by structures called lateral bodies, that are composed of viral proteins (Cyrklaff 
et al, 2005). The poxvirus virions also include the multisubunit viral DNA dependent  
ribonucleic acid (RNA) polymerase, the mRNA capping enzyme and other factors 
needed for the early stages of transcription (Senkevich et al, 2005) .  
 
 
Fig.2.1 Poxvirus morphology (ViralZone.ExPASy.SIB, with permission). 
2.1.3 Replication cycle 
The binding of the virion is determined by viral proteins and by glycosaminoglycans 
(GAGs) on the surface of the target cell (Lin et al, 2000). The precise mechanism of 
poxvirus entry is not fully understood, but it has been proposed that a 
macropinocytosis process is involved for the release of the core into the cytoplasm 
(Fig. 2.2) (Mercer & Helenius, 2008). Within this core around 100 mRNAs are 
transcribed, facilitated by the viral ‘early’ transcription machinery that is packaged into 
the virion (Broyles, 2003). The early mRNAs synthetized inside the genome-
containing core are then extruded to the cytoplasm for translation. Poxviral proteins 
translated from these early mRNAs serve to replicate the virus DNA, modify the host 
cell to the viral advantage and to block the host innate immune response (Joklik, 
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1964; Sarov & Joklik, 1972; Smith et al, 1997). For degradation of the core and 
uncoating of the DNA early viral proteins have to be expressed, one or more of the 
early proteins are responsible for making the ubiquitinated core proteins accessible to 
the proteasome and then degraded (Mercer et al, 2012). 
 
Fig.2.2 Cellular cycle of poxvirus infection (ViralZone.ExPASy.SIB, with permission). 
After DNA replication has started, the transcription of intermediate genes 
commences, which are fewer in number and encode mostly regulatory proteins that 
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induce the transcription of late genes. The late genes encode most of the virus 
proteins for building new virus particles and enzymes that are packaged into virions 
to initiate transcription in the next viral cycle (Assarsson et al, 2008).  Unlike early 
transcription the intermediate and late transcription stages require the interaction with 
host-derived transcription factors that contribute to the efficiency of these later waves 
of viral gene expression (Katsafanas & Moss, 2004; Rosales et al, 1994; Sanz & 
Moss, 1998).  
Accumulation of late viral gene products drives the progressive morphogenesis and 
assembly of infectious virus particles, initially as IMV virions, in structures known as 
viral factories (Sodeik & Krijnse-Locker, 2002). IMV assemble and migrate via 
microtubule mediated trafficking and wrap with Golgi-derived membranes to form 
internal enveloped virus (Fig. 2.2)  (IEV) (Sodeik & Krijnse-Locker, 2002). IEV fuses 
with the cell surface membrane to form cell-associated enveloped virus (CEV), which 
is either extruded from the cell by actin-tail polymerization or released to form free 
extracellular enveloped virus EEV (Fig. 2.2) (Roberts & Smith, 2008).  
2.1.4 Poxviral diseases in humans 
Smallpox was a devastating human infectious disease caused by variola virus (genus 
Orthopoxvirus), during the last millennia it has been estimated that this disease was 
responsible for 10% of mortalities worldwide (Mercer, 1985). Smallpox made no 
distinctions; it affected all ages and socioeconomic classes. The main symptoms 
included high fever, chills or rigors, cephalagia, characteristic dorsal-lumbar pain, 
myalgias, prostration, nausea and vomiting. After 4 days, the fever receded and a 
rash appeared around the eyes, on the face and subsequently would cover the whole 
body. Other clinical forms of the disease existed, persons with fulminating smallpox 
(purpura variolosa) had mucocutaneous hemorrhages that preceded the appearance 
of the typical skin lesions (Barquet & Domingo, 1997). In malignant smallpox, the 
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rash had a slow evolution characterized by pseudocropping, subconjunctival 
hemorrhages, and death when lesions on the limbs and face were confluent (Barquet 
& Domingo, 1997). The mortality rate associated with smallpox varied between 20% 
and 60% and most survivors were left with disfiguring scars (Mercer, 1985).   
In 1796 Edward Jenner performed an experiment that laid the groundwork for the 
eradication of smallpox and by promoting vaccination using a cowpox infection 
(Baxby, 1996). Two centuries later in May 1980 and after a global vaccination 
campaign the World Health Organization declared that smallpox had been eradicated 
(Fenner, 1980). To date it is the only human infectious disease to be completely 
extinct. However samples stocks of variola still exists in the United States at the 
Centers for Disease Control and Prevention and by Russia at the State Research 
Centre of Virology and Biotechnology (Li et al, 2007). Although, recently forgotten 
vials containing smallpox were founded in the National Institutes of Health (NIH) 
campus in Bethesda, Maryland, and many experts believe that numerous stocks still 
exist around the world (Reardon, 2014). Thus, the probability that stolen variola 
cultures may be used as bioterrorist weapons remains an important subject of 
international concern.  
Recently, concern has been raised about  potential outbreaks of infectious diseases 
that clinically mimic smallpox, particularly if it is caused by a novel or emerging agent. 
That threat of novel zoonotic infections was confirmed in 2003, when an outbreak of 
a pox-like illness in people occurred in the central USA. This outbreak was attributed 
to the monkeypox virus (MPV), a rare zoonosis that can cause illness clinically 
indistinguishable from smallpox (Di Giulio & Eckburg, 2004; Reed et al, 2004). The 
natural animal reservoir of the MPV is unknown but it is believed that rodents were 
the possible source of its introduction into the United States (Reed et al., 2004). That 
outbreak was not particularly aggressive; however it is better to be prepared for 
Literature review____________________________________________________________ 
15 
 
future threats where a VACV vector would be required as a vaccine against potential 
poxviral zoonotic infections.  
2.1.5 Immune evasion  
VACV like other poxviruses carry a large genome that encode multiple classes of 
immunomodulatory proteins that have evolved specifically to inhibit diverse process 
such as apoptosis, the production of interferons (IFNs), chemokines, inflammatory 
cytokines, the activity of cytotoxic T lymphocytes (CTLs), natural killers (NK) cells, 
complement and antibodies (Haga & Bowie, 2005; Seet et al, 2003). Poxvirus 
immunomodulatory proteins can be divided by function in three distinct strategic 
classes: virostealth, virotransduction and viromimicry (Johnston & McFadden, 2003). 
Virostealth is the capacity that some poxviruses possess to mask the visible signals 
associated with the infection, mostly by downreagulating the antigen recognition or 
blocking the presentation of viral antigen to immune cells. Major histocompatibility 
complex class I (MHCI) depletion and cluster of differentiation 4 (CD4) coreceptor 
downregulation are the main examples of this mechanism (Moss & Shisler, 2001).  
Virotransducers are intracellular viral proteins that inhibit innate antiviral pathways, 
such as apoptosis, proinflammatory cascades or the induction of the antiviral state; 
several of these poxvirus genes have been hijacked directly from the host immune 
system (Seet et al., 2003). Virotransducers can also target host signal transduction 
pathways that influence host range (Johnston & McFadden, 2003). One of the best 
characterized is VACV E3, a doublestranded RNA (dsRNA)-binding protein that 
inhibits activation of protein kinase RNA-activated (PKR) and blocks IFN responses 
by sequestering dsRNA molecules, also affect the IFN-stimulated genes (ISG) gene 
2'-5'-oligoadenylate synthetase (OAS) antiviral pathway (Davies et al, 1993). VACV 
also encode several immunomodulators that interfere with different pattern 
recognition receptor (PRR) activation pathways, including toll-like receptor (TLRs) 
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and cytoplasmatic retinoic acid inducible gene (RIG-I)-like receptors (RLRs) (Haga & 
Bowie, 2005). One of the main signaling factors blocked by numerous poxviral 
proteins (including N1, B14, K1L and M2) is the nuclear factor κappa-enhancer of 
activated B cells (NF-κB), a key mediator of inducible transcription in the innate 
immune system (Mohamed & McFadden, 2009). 
Viromimicry includes virokines and viroceptors that are virus-encoded proteins which 
mimic host cytokines, chemokines and their receptors. These proteins establish a 
protected microenvironment for the virus by blocking extracellular communication 
signals. The main extracellular pathways targeted are involved in early inflammatory 
responses, and include the modulation of IFNs and proinflamatory cytokines as tumor 
necrosis factor alfa (TNF-α) and interleukin 1 beta (IL-1β) (Bahar et al, 2008; 
Johnston & McFadden, 2003).  
2.2 Modified Vaccinia virus Ankara (MVA) 
 
Modified Vaccinia virus Ankara (MVA) is a highly attenuated VACV strain that is not 
able to replicate in human and most other mammalian cells. MVA was generated by 
serial passages of a Turkish smallpox vaccine strain named Chorioallantois vaccinia 
Ankara (CVA) in chicken embryo fibroblast (CEF) (Mayr & Munz, 1964; Mayr et al, 
1978). After more than 500 in vitro passages the virus has lost  approximately 30 kb 
of DNA, equivalent to 15% of the parental viral genome (Fig. 2.3) (Mayr et al, 1978; 
Meyer et al, 1991). The main DNA loss is located in six major deletion sites at both 
ends of the genome, additionally it accumulated many point mutations and short 
deletion in other genes (Fig. 2.3)  (Antoine et al, 1998).  As result MVA lacks the 
capacity to encode several proteins involved in immune-modulation and host-
interaction process (McFadden, 2005; Meyer et al, 1991).  
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Fig.2.3 Generation of modified vaccinia virus Ankara. (Adapted from Sutter LMU thesis 
1990, with permission) 
Consequently MVA is replication-deficient in most of mammalian cells (Blanchard et 
al, 1998; Carroll & Moss, 1997), as viral multiplication is arrested at later stage of the 
virus cycle after accumulation of immature particles in the cytosol (McFadden, 2005; 
Sutter & Moss, 1992). Due to its safety and limited replication, MVA was tested as 
smallpox vaccine by the Bavarian State Vaccine Institute and more than 120 000 
individuals were vaccinated without any major adverse events (Stickl et al, 1974). 
Despite the loss of several genes, MVA has a potent immunogenic capacity 
compared with other VACV strains. Even though the replication of MVA is abortive in 
most of mammalian cells, the virus is still able to efficiently express recombinant 
genes, which makes it a promising candidate vector for antigen delivery against 
different infectious diseases in animals and humans (Sutter & Moss, 1992).  
MVA no longer encodes many of the known poxviral virulence factors, and even 
though the impaired replication capacity of MVA is well established, the genetic basis 
for this host range restriction is not fully understood (Johnston and McFadden, 2003). 
conserved genes 
CVA 
208 kb 
I V II VI III IV 
572 serial passages in CEF 
MVA 
178 kbp 
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Two of the classical host range genes of VACV are truncated in MVA: K1L and C12L, 
while E3L, K3L and C7L are still present (Antoine et al, 1998). The reconstitution of 
these host range factors only partially rescue the replication capacity of MVA in 
selected cell lines (Sutter et al, 1994; Wyatt et al, 1998). The lack of the pathogenicity 
of MVA has been mostly associated with the loss of gene function including the six 
major deletions in its genome but also the many other mutations present in the MVA 
genome (Antoine et al, 1998; Meyer et al, 1991). This was nicely illustrated by a 
study by Meisinger et al., attempting to obtain an MVA-like phenotype by introducing 
the six major deletions in a CVA genome. The results  showed that CVA variants with 
the major deletions were only incompletely attenuated in a murine model and did not 
reproduce the characteristic host range phenotype of MVA (Meisinger-Henschel et al, 
2010). Thus point mutations and/or smaller deletions in gene sequences outside the 
six major deletions definitively contribute to the properties of MVA attenuation. More 
studies are required to elucidate the full genetic basis of the safety and 
immunogenicity of this vector virus. Interestingly inactivation of the E3L gene in the 
MVA genome resulted in enhanced production of Type I IFNs in CEFs, suggesting 
that the capacity of MVA to stimulate innate response can be also further improved 
by reasonable mutagenesis (Hornemann et al, 2003; Ishii et al, 2006) .  
Immunization with MVA protects mice against the virulent VACV Western Reserve 
(WR) infection and also protects them from the lethal challenge with mousepox virus, 
in a prophylactic and therapeutic approach (Drexler et al, 2003; Paran et al, 2009; 
Samuelsson et al, 2008; Staib et al, 2006). Additionally Earl et al. have shown a high 
protective capacity of MVA vaccine in non-human primates against monkeypox 
challenge (Earl et al, 2004; Volz & Sutter, 2013).  
Some clinical trials using recombinant MVA for treatment of human 
immunodeficiency virus (HIV) infection, malaria and other infectious diseases has 
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been encouraging and confirm their safety (Cosma et al, 2003; Gilbert, 2013; Gilbert 
et al, 2006). MVA is a very promising viral vector vaccine candidate because it has a 
high safety profile combined with robust immunostimulatory abilities while its capacity 
to deliver recombinant antigens is conserved. In the last decades, MVA has been 
proposed as a vaccine against a possible smallpox-related bioterrorist attack 
(Belyakov et al, 2003). While there is a major interest in MVA as a vector and as a 
vaccine,  how it activates the innate immune system remains still incompletely 
understood. It is likely that these innate responses also influence the extent and 
efficacy of responses by the adaptive immune system. For these reasons it is crucial 
to better elucidate the cellular and molecular immune mechanisms modulated by 
MVA, since this should help in the rational development of new MVA-based vaccines.  
2.3 Innate immune activation 
The host immune response to VACV infection consists of two steps. Firstly innate 
effectors such macrophages, NK cells and type I IFNs are critical in the early phase. 
Secondly, adaptive antigen-specific T and B cell response, which are essential for 
clearance of the virus and establishment of immunity (Haga & Bowie, 2005).  
Particularly MVA has the ability to activate robust innate immune responses. 
2.3.1 Activation of pattern recognition receptors 
Viral infections are detected by sensor molecules, which initiate the antiviral response 
and activate the innate immune response, including the secretion of type I IFNs and 
proinflamatory cytokines (Yoneyama & Fujita, 2010b). Three main PRRs families 
have been related with VACV sensing: TLRs, RLRs and DNA sensor molecules (Fig. 
2.4) (Peters et al, 2013; Yoneyama & Fujita, 2010b). Each TLR detects distinct 
pathogen-associated molecular patterns (PAMPs) derived from pathogens, such as 
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lipoproteins and lipopolysaccharides (LPS) which are sensed by cell surface TLR2 
and TLR4 respectively.  
 
Fig.2.4 Pathways Coupling Virus Recognition to Type I IFN expression.   
Leucine-rich repeat (LRR), caspase activating recruitment domain (CARD), RNA-binding 
domain (Helicase); RD: repressor domain (RD), Z-DNA binding domains (Za, Zb), and 
signaling domain (SD). (Adapted from Pichlmair et al. 2007, with permission) 
 
Viral nucleic acids are detected in endosomal compartments: ds RNA (TLR3), single-
stranded (ss) RNA (TLR7 and TLR8) and CpG motifs in DNA (TLR9) (Fig. 2.4) 
(Kawai & Akira, 2007; Uematsu & Akira, 2004). Upon recognition of respective 
PAMPs, TLRs recruit specific adaptor molecules such as myeloid differentiation 
primary response gene 88 (Myd88) and TIR-domain-containing adapter-inducing 
interferon-β (TRIF) and initiate downstream signaling events that lead to the 
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secretion of IFNs, inflammatory cytokines and chemokines (Fig. 2.4)  (Kawai & Akira, 
2011). RLRs are sensor molecules for the detection of viral RNA in the cytoplasm of 
infected cells, in mammals three family member have been identified RIG-I, 
melanoma differentiation associated gene 5 (MDA5) and laboratory of genetics and 
physiology 2 (LGP2) (Fig. 2.4) (Pichlmair & Reis e Sousa, 2007; Yoneyama et al, 
2005). Both RIG-I and MDA-5 induce cellular signaling through the adaptor 
mitochondrial antiviral signaling proteins (MAVS) (Seth et al, 2005). In addition viral 
RNA activates antiviral effectors including PKR, OAS, adenosine deaminase acting 
on RNA (ADAR) and RNAse L (Samuel, 2001).  
The restrictive replication phenotype of MVA is most likely linked to the cellular 
signals triggered when the virus enters the host cell, which this vector is not able to 
evade. The use of microarray studies in infected dendritic cells has shown that MVA 
induces the expression of several genes involved in innate immune response 
including RIG-I, MDA-5 and TLRs (Guerra et al, 2007). Additionally a report from 
Delaloye et al. has revealed that in bone marrow derived macrophages (BMDM) the 
TLR2-TLR6-Myd88 and MDA5 pathways are important in modulating the cytokine 
and chemokine profile produced by MVA infection. Particularly a reduced expression 
of RIG-I and MDA-5 by shRNAS indicated that sensing of MVA and production of 
IFN-β and IFN-β-dependent chemokines was controlled by MDA-5 pathway in 
macrophages (Delaloye et al, 2009). Also Pichlmair et al. showed that dsRNA 
extracted from VACV-infected cells could induce MDA-5-dependent Type I IFN 
(Pichlmair et al, 2009).  
In the last years several studies showed the relevance of TLR2 in sensing VACV 
infection, however most of the results in vivo are quite inconsistent. Barbalat et al. 
claimed that TLR2 activation by VACV lead to the secretion of IFNs in monocytes 
(Barbalat et al, 2009), while another study reported significant decrease of 
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inflammatory cytokines in Tlr2-/- mice (Zhu et al, 2007).  On the other hand, one study 
demonstrated that TLR2 has a minor influence in the course of VACV infection in a 
murine disease model (O'Gorman et al, 2010). Another group has observed that 
whilst the CD8 T cell response is MyD88-dependent the Tlr2-/- mice are still able to 
produce a robust antiviral immune response (Zhao et al, 2009). These last results are 
in line with the conclusions of Davies et al., who recently have shown that in mice, 
MyD88 is required for efficient induction of CD4+ T cell and B cell responses, 
whereas TLR2 is disposable for control of virus replication and induction of adaptive 
immunity to VACV infection (Davies et al, 2014). Thus, based on these contradictory 
results, there has been increased concern that many reports involving TLR2 in the 
sensing of VACV are artifacts of possible contamination, especially as the specific 
TLR2 ligand so far remains uncharacterized (Davies et al, 2014; Price et al, 2013).  
Mice lacking TLR9 are more susceptible to Ectromelia virus (ECTV) infection, the 
causative agent of mousepox, none the less MVA still protects from disease in Tlr9-/- 
mice (Samuelsson et al, 2008). In contrast, in a mouse model, activation of TLR3 
contributed to the pathogenesis of the virulent VACV WR (Hutchens et al, 2008). 
Mice lacking the adaptors of TLR signaling MyD88 and TRIF showed IFN-α 
responses that were only slightly reduced compared to those of wild type mice 
(Waibler et al, 2007).   
2.3.2 Type I Interferon 
Type I Interferons (IFN-α and IFN-β) are a group of secreted cytokines that constitute 
the first line of defense against viral infection and can induce direct antiviral effects 
(Honda et al, 2006; Sen, 2001). These cytokines have various biological activities, 
including anti-viral, anti-proliferative and immunomodulatory effects. After induction, 
all type I IFNs bind one common type I IFN receptor (IFNAR) which leads to 
downstream signaling resulting in the expression of more than 300 ISG (Fig. 2.5) 
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(Honda et al, 2006; Samuel, 2001). The ISG are involved in eliminating viral 
components from infected cells, inducing apoptosis of infected cells and conferre 
resistance to viral infection on uninfected cells (de Veer et al, 2001). Most of the ISG 
genes are antiviral effectors including the IFN-induced PKR and OAS (Fig. 2.5), 
which are then activated by dsRNA produced during virus infection (Sen & Sarkar, 
2007).  
Nevertheless the effects of IFNs are not limited to induction of ISG, they also have a 
great impact on the systemic immunity. Indeed, it has been reported that IFNs are 
involved in the maturation of DCs, including the cross-presentation of viral antigens 
for CD8+ T cell and the activation of NK cells (Burshtyn, 2013; Stetson & Medzhitov, 
2006). IFN signaling in poxvirus infection has also been proposed to play a role in the 
generation of a virus specific CTL response (Kolumam et al, 2005). IFNs have been 
implicated in the induction of chemokine expression in bone marrow macrophages 
during murine cytomegalovirus (MCMV) infection (Crane et al, 2009). Mice deficient 
in IFN receptors are abnormally susceptible to VACV showing the relevance of IFNs 
in controlling VACV infection (van den Broek et al, 1995) even an IFN therapy 
protects the mice from the lethal challenge with VACV WR infection (Liu et al, 2004).  
VACV like many poxviruses evades this response using various strategies such as 
the direct suppression of IFN induction or blocking the IFN signaling pathways (Fig. 
2.5)  (Perdiguero & Esteban, 2009; Smith et al, 2013). VACV encodes soluble 
viroceptors like B8 that block the binding of IFNs to their cell surface receptors 
(Jackson et al, 2005). VACV E3L, K3L, C7L, K1L and VH1 proteins block distinct 
intracellular pathways upstream and downstream of IFN activation (Fig. 2.4)  
(Perdiguero & Esteban, 2009; Seet et al, 2003; Smith et al, 2013).  
Literature review____________________________________________________________ 
24 
 
 
 
Fig.2.5 IFN signalling and its antagonism by VACV. The positions at which viral proteins 
can inhibit the production or action of IFN are shown by red stars, and many of these are 
illustrated by VACV proteins. (Adapted from Smith et al 2013, with permission).  
 
Since MVA is highly attenuated, it is not a surprise that the virus has lost several 
proteins that impair IFNs functionality (Antoine et al, 1998). Therefore MVA has the 
capability to induce higher levels of IFNs than other VACV strains (Buttner et al, 
1995; Waibler et al, 2007), a rapid local immune response and IFN-dependent 
expansion of virus specific CD8+ T cells (Frenz et al, 2010). However MVA still 
contains some of these genes like E3L and C7L, indicating that it is possible to 
further increase its immunostimulatory capacity (Antoine et al, 1998).  
2.3.3 Chemokines 
Chemokines are a superfamily of small secreted proteins that are classified into four 
subfamilies denominated C, CC, CXC, and CX3, depending of the arrangements of 
disulphilde bridges between cysteine residues near their amino terminus (Zlotnik & 
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Yoshie, 2000). Chemokines are chemoatractant molecules that have a major role in 
the inflammatory response to pathogen infections (Alcami, 2003). They modulate the 
migration of leukocytes and up-regulate the expression of leukocytes adhesion 
molecules. Furthermore, chemokines play a critical role in modulating the innate and 
adaptive host responses to viral infections (Fauci, 1996; Mahalingam et al, 1999).  
Many poxviruses including VACV express proteins that interfere with chemokine 
functions (Alcami et al, 1998). B7 is one of these proteins, which is not functional in 
MVA (Alejo et al, 2006). Nevertheless, some other genes such as A41L and B15R 
are still present in the genome of MVA, which when deleted induce a stronger CD8+ 
T cell response and conferre better protection to subsequent challenges with virulent 
VACV (Clark et al, 2006; Staib et al, 2005).  
Lehmann et al. showed that infection of human monocytic cells with MVA induces a 
strong chemokine response, with a pronounced upregulation of CC and CXC 
chemokines. Further antibody inhibition studies in vitro demonstrated that the 
chemokine (C-C motif) ligand 2 (CCL2) induces chemotaxis in the human monocytic 
cell line THP-1. The importance of CCL2 was corroborated in mice, since it was 
shown that MVA and no other VACV strains triggers immigration of monocytes, 
neutrophils and CD4+ lymphocytes into the lung after intranasal infection, correlating 
with the strong expression of CCL2. Also, using CCL2-deficient mice it was 
demonstrated that CCL2 plays a key role in the early respiratory migration of 
leukocytes triggered by MVA (Lehmann et al, 2009). CCL2 is a key factor in the 
initiation of inflammation and recruitment of monocytes, memory T cells and dendritic 
cells to the site of infection (Yadav et al, 2010). Usually the CCL2 expression is 
regulated at the transcriptional level by stimulatory cytokines like TNF-α, acting as a 
key mediator the NF-κB in the induction of CCL2 expression (Sung et al, 2002). 
Some studies have reported that IFNAR stimulation lead to the induction of CCL2 
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expression (Conrady et al, 2013). In fact systemic release of IFN during MCMV 
infection drives expression of CCL2 in bone marrow cells promoting monocyte 
migration to the site of infection (Crane et al, 2009).  
2.3.4 Macrophages  
Cells of the monocyte/macrophage lineage have an important function as antigen 
presenting cells (APC) for the activation of T cells and in virus-host interactions. 
These cells play a key role in poxviral immunity.  In vitro assays have shown that 
VACV preferentially infects monocytic cells (Sanchez-Puig et al, 2004) and induces 
apoptosis in a murine macrophage cell line (Humlova et al, 2002). In mouse 
peritoneal macrophages, the VACV replication cycle was found to be abortive with 
only early viral protein expressed, the absence of viral DNA synthesis and late 
proteins prevents assembly of progeny virions (Natuk & Holowczak, 1985). In 
contrast, in activated rabbit peritoneal macrophages the virus replication cycle is 
blocked at a later stage after DNA synthesis (Buchmeier et al, 1979). Curiously 
VACV replicates in macrophages from naive but not immune animals (Avila et al, 
1972), with the same result obtained in vivo (McLaren et al, 1976). Mice depleted of 
macrophages are unable to control VACV infections due to impaired virus clearance 
and antiviral response (Karupiah et al, 1996). In fact, monocytic cells appear to have 
an important role in limiting virus replication and dissemination (Chapes & Tompkins, 
1979). Additionally, murine alveolar macrophages limit the spread of VACV WR, and 
depletion of these cells increases virus replication and dissemination (Rivera et al, 
2007). In a mouse model of intranasal infection, Lehmann et al. demonstrated that 
MVA but no other VACVs strains triggered the immigration of leukocytes into the lung 
(Lehmann et al, 2009). This early immigration of leukocytes has been correlated with 
the ability of MVA to confer a short-term immunization more efficiently than other 
VACV strains, and thus is able to protect mice 48 h before a lethal challenge with the 
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virulent VACV WR (Staib et al, 2006). Also, postexposure immunization of MVA 
protects the mice against lethal challenge with ECTV (Paran et al, 2009) .  
Besides the direct role played by monocytic cells in controlling poxvirus infection and 
in the primary innate immune response, there is evidence that these cells may also 
play a critical role in the development and execution of the adaptive immune 
response by augmenting the activation of CTLs (Karupiah et al, 1996; Narni-
Mancinelli et al, 2011). Therefore monocytes and macrophages are key players in 
modulating the adaptive response and in the induction of a long term poxviral 
immunity. 
2.4 O-GlcNAcylation 
O-linked beta-N-acetylglucosamine (O-GlcNAc) modification of nuclear and 
cytoplasmatic proteins is important for many cellular processes like protein 
expression, degradation and trafficking (Hart et al, 2007). O-GlcNAc modification of 
proteins is catalyzed only by one enzyme called O-linked N-
acetylgucosaminyltransferase (OGT) and is removed by the enzyme beta-N-
acetylglucosaminidase (Hart et al, 1989). OGT is ubiquitously expressed with high 
transcript levels in macrophages (Hanover et al, 2010). O-GlcNAcylation is one of the 
most common posttranslational modifications and together with phosphorylation 
plays a reciprocal role in regulation of protein function by competing for modification 
of the same serine or threonine residues (Copeland et al, 2008; Slawson & Hart, 
2003).  Many transcription factors have been shown to be modified by O-linked 
GlcNAc modification, which can influence their transcriptional activity, DNA binding, 
localization, stability and interaction with other co-factors (Ozcan et al, 2010). Some 
of these transcription factors include NF-κB, nuclear factor of activated T-cells 
(NFAT), tumor protein 53 (p53), specificity protein 1 (Sp1) and others. In fact over 
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25% of the O-GlcNAcylated proteins are involved in transcriptional regulation (Ozcan 
et al, 2010).   
Cells of the immune system undergo large changes in their metabolic rates when 
they are activated by danger signals. Some of the cells enter a phase of extensive 
and rapid cell proliferation, altering the level of cellular glucose concentration which is 
though to strongly affect the levels of O-GlcNAc-modified proteins (Golks & Guerini, 
2008). Initial reports by Kearse et al. showed that treatment with phorbol 12-
myristiate 13-acetate (PMA) lead to an increase in nuclear and cytoplasmatic O-
GlcNacylated proteins in lymphocytes (Kearse & Hart, 1991).  More recent work has 
reported that O-GlcNAcylation of the transcription factors NF-κB and NFAT is needed 
for  productive T-cell activation in a T-cell receptor-dependent manner (Golks et al, 
2007). Similar effects for NFAT and NF-κB were observed during B-cell receptor 
(BCR)-dependent activation of B cells (Golks et al, 2007). The requirement of the 
active OGT enzyme for productive T cell activation was consistent with the reduction 
of CD4+ T cells observed in transgenic mice carrying an inactivating T-cell deletion in 
the OGT gene (O'Donnell et al, 2004). In neutrophils, chemokine stimulation lead to 
an increase in O-GlcNAcylated proteins (Kneass & Marchase, 2004) and this O-
GlcNAc modification affects their motility and activation (Kneass & Marchase, 2005). 
Additionally, it was reported that in a monocytic cell line the expression of 
macrophage Inflammatory proteins 1-α ( MIP-1α) and MIP-1β was regulated by the 
O-GlcNAcylation of nuclear proteins (Chikanishi et al, 2010). 
Although there are several viral proteins that are subject to O-GlcNAc modification 
(Hart et al, 2007; Love & Hanover, 2005), the relevance of this posttranslational 
modification for host-pathogen interactions has been not extensively studied. 
Perhaps one of the few examples is the report from Jochman et al., where they 
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demonstrated that the O-GlcNAcylation of the transcription factor Sp1 inhibits the 
activity of HIV-1 LTR promoter (Jochmann et al, 2009).    
2.5 Objectives 
MVA is gaining increased importance as a candidate to be used as an attenuated live 
vaccine against various infectious diseases in humans and animals. Therefore, it is 
necessary to gain a better understanding of the mechanisms of MVA-induced 
immunity. This study aims to (i) Examine which viral components are important for 
MVA-induced cytokine expression in infected monocytes and macrophages. (ii) Test 
whether IFNAR modulates CCL2 production in MVA-infected BMDM. (iii) Determine 
whether O-GlcNAc modification modulates CCL2 expression in MVA-infected 
monocytes.  
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3. MATERIALS AND METHODS 
3.1 Materials 
3.1.1 Media and Cell culture 
Reagent  
 
Supplier 
RPMI (Endotoxin free)  
 
Sigma 
DMEM (Endotoxin free) 
 
Biochrom  
Fetal Calf Serum (FCS) (VLE) 
 
Biochrom 
PBS (Endotoxin free) 
 
Biochrom 
Trypsin Solution  
 
Sigma 
Penicillin/streptomycin 
 
Sigma 
Adenosine N1-oxide (ANO) 
 
SIA MolPort (Lithuania) 
Cytosine arabinoside (AraC) 
 
Sigma 
LPS 
 
Sigma 
P3CSK4 
 
Sigma 
Glutamine 
 
Sigma 
O-(2-Acetamido-2-deoxy-D-
glucopyranosylidene) amino N-phenyl 
carbamate ( PUGNAC) 
Sigma 
Alloxan 
 
Sigma 
 
3.1.2 Viruses 
Virus 
 
Supplier 
MVA (cloned isolate F6)  
 
Dr. Sutter, G. (LMU) 
VACV WR provide by Dr. Moss, B. 
 (NIH, Bethesda, MD). 
VACV Wyeth 
 
provided by Dr.  Moss, B. 
 (NIH, Bethesda, MD). 
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3.1.3 Oligonucleotides 
Target Gene 
 
Sequence in 5’-3’orientation Size (bp) 
 
murine GAPDH-F 
GAC AAC TCA CTC AAG ATT GTC AG  
540 
 
murine GAPDH-R 
GTA GCC GTA TTC ATT GTC ATA CC 
 
murine TNF-F 
CAC TCC CCC AAA AGA TGG  
445 
 
murine TNF-R 
GAG ATA GCA AAT CGG CTG AC 
 
murine IFN--F 
ATG GAA AGA TCA ACC TCA CCT AC  
502 
 
murine IFN--R 
TAG ATT CAC TAC CAG TCC CAG AG 
 
murine CCL2-F 
AAGCCAGCTCTCTCTTCCTC  
605 
 
murine CCL2-R 
GATTCACAGGAGAGGGAAAAATG 
 
murine CXCL10-F 
TGAAAAAAGAATGATGAGCAGAG  
400 
 
murine CXCL10-R 
GTACAGAGCTAGGACAGCCATC 
 
human GAPDH-F 
AGCCACATCGCTCAGAACAC  
606 
 
human GAPDH-R 
GAGGCATTGCTGATGATCTTG 
 
human IFN--F 
TGC TCT CCT GTT GTG CTT CTC C  
459 
 
human IFN--R 
CAG TGA CTG TAC TCC TTG GCC TTC 
 
human CCL2-F 
CAA ACT GAA GCT CGC ACT CTC GCC  
550 
 
human CCL2-R 
GCA AAG ACC CTC AAA ACA TCC CAG 
 
human CXCL8-F 
GTA AAC ATG  ACT TCC AAG CTG G  
400 
 
human CXCL8-R 
AGA CCC ACA CAA TAC ATG AAG TG 
 
VACV E3L-F  
GATCTATATTGACGAGCGTTCTG  
201 
 
VACV E3L-R  
GTTGTCATAAACCAACGAGGAG 
 
VACV B15R-F  
TGGTATGTCCCAATATTAATGC  
545 
 
VACV B15R-R 
AAACGTTGTAGCATCTTCTTCC 
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3.1.4 Antibodies 
rat anti-VACV C7 Hybridoma culture supernatants 
(Backes, 2010) 
mouse anti-GAPDH 
 
Millipore 
Secondary horseradish peroxidase 
(HRP)-conjugated goat anti-rat 
polyclonal IgG 
 
BioLegend 
Secondary HRP-conjugated goat anti-
mouse IgG/IgM 
 
Jackson ImmunoResearch 
 
 
3.1.5 Buffers 
DNA loading buffer 5x 
0.25% bromophenol blue, 40% (w/v) glycerol  in distilled water and 60 µM 
EDTA 
 
Phosphate buffered saline (PBS) pH 7.4 
140mM NaCl , 5.4mM KCl, 9.7mM Na2HPO4x2H2O, 2mM KH2PO4 
 
TAE buffer 50x pH 8.0 
2M Tris-acetate, 0.5M NaCl, 50mM EDTA 
 
TBS pH 7.6 
150 mM NaCl, l50 mM, Tris-acetate 
 
 
3.1.6 Cell migration  
Reagent/Equipment  
 
Supplier 
FACSCanto II 
 
BD Biosciences 
MACSQuant VYB 
 
Miltenyi 
Microplate Zentrifuge 5810R 
 
Eppendorf 
96 well (V bottom for FACS) 
 
Corning Life Sciences 
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3.1.7 Western Blot and ELISA  
 
Reagent/Equipment 
 
Supplier 
Colour plus protein ladder 
 
New England Biolabs 
4-20% Criteron TGX stain free gel 
 
Bio-Rad 
 
Laemmli buffer (x4) 
Bio-Rad 
 
Mini PROTEAN tetra cell 
(electrophoresis tank) 
Bio-Rad 
 
Trans-Blot Turbo Mini Nitrocellulose 
transfer pack 
Bio-Rad 
 
Trans-Blot Turbo Transfer system 
Bio-Rad 
 
Tris Glycine solution (10x) 
Bio-Rad 
 
Tween20 
Sigma 
 
β-Mercaptoethanol 
AppliChem 
 
ChemiDoc MP imager 
Bio-Rad 
 
Clarity ECL Susbtrate 
Bio-Rad 
 
Image Lab. 5 Software 
Bio-Rad 
 
Nonfat dry milk 
Applichem 
 
96 well (Maxisorp, flat bottom for ELISA) 
Nuc 
Sulphuric acid 1 M  
 
Roth 
 
Sunrise microplate reader 
Tecan 
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3.2 Methods 
3.2.1 Viruses 
VACV strain Western Reserve (WR) and VACV Wyeth were originally provided by 
Bernard Moss (NIH, Bethesda, MD). The two VACV strains and MVA (cloned isolate 
F6) were propagated in chicken embryo fibroblasts (CEF). Virus stocks were purified 
by ultracentrifugation and titrated using standard methodology (Kremer et al, 2012). 
All the virus stocks were tested for contamination with Mycoplasma by real-time PCR 
with the kit Venor®GeM-qEP (Minerva Biolabs GmbH, Berlin, Germany).  
Viruses were treated with a UV dosage as indicated using the Stratalinker UV 
Crosslinker 1800 (Stratagene, USA). Viruses were resuspended at 1X108 PFU in cell 
culture medium were placed on ice and treated with the indicated dosages of UV 
light.  
3.2.2 Cell lines 
The Human monocytic cell line (THP-1) and the Baby hamster kidney cells (BHK-21) 
were grown in RPMI 1640 medium supplemented with 10% fetal calf serum (FCS) 
(Biochrom AG, Berlin, Germany). L929 cells were maintained in RPMI 1640 medium 
supplemented with 10% FCS and 100 U/ml penicillin and streptomycin. To make 
conditioned medium for the differentiation of bone marrow cells into bone marrow 
derived macrophages (BMDM), L929 cells were grown for 10 days in medium that 
was then centrifuged, filtered through a 0.2 µm filter (BD biosciences, San Jose, CA) 
and stored at -20 °C. The permanent cell lines were systematically tested for 
mycoplasma contamination. 
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3.2.3 Isolation of murine bone marrow cells and generation of BM-derived 
macrophages (BMDM) 
 Bone marrow cells were flushed from the femurs and tibiae of mice with very-low 
endotoxin (VLE)-RPMI 1640 medium (Biochrom) and supplemented with 10% FCS. 
Red cells were lysed using a lysis buffer (R&D Systems) and then the cells were 
washed and seeded in VLE-RPMI 1640 medium supplemented with 10% FCS, 20% 
conditioned medium from L929 cells and 100 U/ml penicillin and streptomycin. For 
removing the fibroblasts, the supernatant containing BM cells was collected after 24 h 
and the cells re-seeded in VLE-RPMI 1640 medium with supplements. After 4 days, 
medium was replaced with VLE-RPMI 1640 medium and supplemented with 10% 
FCS, 10% L929 conditioned medium and standard antibiotics. On day 7 post 
isolation, macrophages were harvested and seeded to a final density of 0.5  106 
cells/ml in 6-well and 24-well cell culture plates (SARSTEDT, Nümbrecht, Germany). 
Differentiation of BMDM was verified by microscopy (Francke et al, 2011).  
3.2.4 Analysis of heated-MVA and UV-irradiated MVA growth 
BHK21 cells were infected with MVA, heated MVA or UV-irradiated MVA at an MOI of 
0.05. After 1 h incubation, cell culture supernatant was replaced with medium 
containing 2% FCS. At 0 h, 12 h, 24 h and 48 h p.i., cells were harvested by scraping 
and frozen until analysis. Viral titers were determined by tissue culture infectious 
dose 50 (TCID50) using Reed-Muench methodology (Reed & Muench, 1937).  
3.2.5 Infection of cells and harvest of samples 
1.5 × 106 / ml BMDM or 1.0 × 106 / ml THP-1 cells were added to 6 well plates in 
RPMI 1640 medium supplemented with 1% FCS and infected with MVA or WR at an 
MOI of 1 and 4 respectively. After 6 h incubation, some cells were lysed for total RNA 
isolation and protein preparation for Western Blot. The rest of the cells were further 
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incubated for 20 h, after which supernatants were harvested. Cells were pelleted and 
supernatants were collected and treated with 1 J of UV for inactivating remaining 
virus and stored at -80 °C.  
3.2.6 RT-PCR 
 Total RNA was extracted after 6 h incubation, using an RNeasy Plus kit (Qiagen, 
Hilden, Germany) and then the cDNA was synthetized using Omniscript reverse 
transcriptase (Qiagen). PCR was carried out as described previously (Lehmann et al, 
2002). The oligonucleotides for amplification of human and murine housekeeping 
genes, specific cytokines as well viral genes were designed using Primer3 software 
(Rozen & Skaletsky, 2000). Sequences of oligonucleotides and PCR product sizes 
are included in Materials. The primers were synthesized by Eurofins Genomics 
(Ebersberg, Germany). PCR products were separated on a 1.5% agarose gel and 
stained with GelRed™ (Biotium, Hayward, CA). Pictures of gels were taken with 
ChemiDoc MP System and analyzed using Image Lab software (BioRad).  
3.2.7 Western Blot  
Cells were lysed in 1  SDS sample buffer including β-mercaptoethanol (BioRad). 
Subsequently, cellular lysates were heated at 95°C for 5 min and subjected to 
sonication for 3 min. Proteins were separated on a 15% Tris-glycine SDS-
polyacrylamid gel then subsequently transferred onto a Protran® nitrocellulose 
membrane (Whatman, Dassel, Germany). Membranes were immunostained using rat 
anti-VACV C7 mAb diluted 1:200 from hybridoma culture supernatants (Backes, 
2010), anti-VACV E3 polyclonal antisera from rabbits 1:1000, and mouse anti-
GAPDH mAb (Biolegend) diluted 1:10.000. Secondary horseradish peroxidase 
(HRP)-conjugated goat anti-rat polyclonal IgG (BioLegend) and HRP-conjugated goat 
anti-mouse IgG/IgM were diluted 1:20.000 (Jackson ImmunoResearch Laboratories, 
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Inc., West Grove, PA) and HRP-conjugated mouse anti-rabbit IgG was diluted 1:5000 
(Jackson ImmunoResearch Laboratories). Detection reagent solutions were used 
from Clarify™ Western ECL substrate Kit (Bio-Rad). The detection of O-GlcNAc 
modified proteins was performed using an O-GlcNAc Western Blot Detection Kit 
(Thermo Scientific) and carried out following the manufacturer’s instructions. Positive 
signals were detected with the ChemiDoc Imager (Bio-Rad) and analyzed using 
Image Lab. 5 Software (Bio-Rad). 
3.2.8 ELISA 
To determine cytokine concentrations in cellular supernatants mouse CCL2 ELISA 
MAX™ Deluxe (BioLegend), mouse TNF-α ELISA MAX™ Deluxe (BioLegend), 
human CCL2 ELISA MAX™ Deluxe (BioLegend) and human CXCL8 ELISA MAX™ 
Deluxe (BioLegend) kits were used and were carried out according to the 
manufacturer’s instructions. Capture antibody was diluted and was added to each 
well of a 96 well plate (NUNC Maxisorp) sealed and incubated over night at room 
temperature. The plate was washed 4x with excess PBS containing 0.01% Tween20 
and dried on absorbent tissue. The plates were blocked by adding 200 μl of Diluent 
Assay and incubated at room temperature for 1 h. A serial dilution of standards was 
prepared and 100 μl each added to the plate, simultaneously with supernatant 
samples and incubated for 2 h at room temperature. The plate was washed 4x. Next, 
a biotinylated secondary detection antibody is added. After 1 h incubation at room 
temperature, the plate was washed 4x and 100μl of Streptavidin-HRP diluted in 
diluent assay was added to each well, then incubated for 30 min at room 
temperature. The plate was washed 5x and developed by addition of 100 μl of 3, 3′, 
5, 5′-tetramethylbenzidine (TMB) Substrate Solution. The reaction was stopped by 
addition 100 μl of 1 M sulphuric acid and optical density was measured at 450 nm on 
a Tecan Sunrise microplate reader. The concentration of the cytokines in 
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supernatants samples were determined by interpolation from the standard curve 
using non-linear regression.  
3.2.9 Chemotaxis assays 
Chemotaxis assays were performed as previously described (Lehmann et al, 2006). 
THP-1 cells were resuspended at a concentration of 1 × 106 cells/ml in RPMI and 
allowed to migrate for 30 min in a 96-well Multi-Screen-MIC plate (8 µm pore size, 
Millipore, Billerica, MA). Cells were incubated with supernatants from THP-1 cells, 
MVA-infected THP-1 cells or MVA-infected THP-1 cells incubated with Alloxan. The 
number of transmigrating cells in the bottom chamber was quantified using the 
MACSQuant VYB flow cytometer (Miltenyi Biotec).  
3.2.10 Statistical analysis 
 All data was assembled using GraphPad Prism 5 (GraphPad Software, Inc., San 
Diego, CA), significance was determined by non-parametric Mann-Whitney U test, a 
P value of <  0.05 was considered to be statistically significant.  
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4. RESULTS 
4.1 Presence of early viral RNA correlates with cytokine expression in MVA-
infected monocytes and macrophages.  
Previously Lehmann et al. have shown that MVA but no other VACV strains elicit 
CCL2 expression in THP-1 cells (Lehmann et al, 2009). However the mechanism of 
chemokine induction in MVA-infected cells is poorly understood. Therefore physically 
and chemically treated MVA was investigated to reveal critical steps of the viral 
replication cycle for induction of cytokine expression. 
4.1.1 MVA-induced chemokine expression is independent of viral DNA 
replication in THP-1 cells. 
A number of cytosolic DNA sensors have been reported in the last years, some of 
them being involved in the recognition of VACV infection (Peters et al, 2013; 
Yoneyama & Fujita, 2010a). Thus, since poxvirus is a DNA virus the contribution of 
viral DNA replication for the induction of chemokine expression in MVA infected 
human monocytic THP-1 cells was tested using cytosine arabinoside (AraC). AraC 
blocks poxviral DNA replication and consequently transcription of viral intermediate 
and late genes is inhibited (Taddie & Traktman, 1993). Therefore, as expected, 
transcription of the late VACV B15R gene but not the early VACV E3L gene was 
affected by AraC in MVA-infected THP-1 cells (Fig. 1A). Importantly, AraC did not 
significantly affect CCL2 and CXCL8 mRNA transcription and protein production, 
indicating that the induction of these chemokines by MVA in THP-1 cells was 
independent of viral DNA replication (Fig. 1).   
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Fig.1. Induction of chemokines in MVA-infected THP-1 cells is independent of viral 
DNA replication. THP-1 cells were infected with MVA at an MOI of 4. Cells and MVA were 
pretreated with AraC (50 µg/ml) as indicated. (A) Total RNA was isolated 6 h p.i. and 
analyzed using specific RT-PCR. (B) CCL2 and CXCL8 protein concentrations in the cell 
culture supernatants were determined by ELISA at 6 h p.i and 24 h p.i. The data shown are 
representative of two independent experiments. Errors bars indicate standard deviations 
(SD).  
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4.1.2 Inhibition of early viral protein synthesis does not affect cytokine 
production in MVA and VACV-infected cells. 
Since AraC has no effect on the synthesis of early viral mRNA and protein (Taddie & 
Traktman, 1993), the relevance of early viral protein expression for cytokine induction 
in MVA-infected cells was investigated using adenosine N1-oxide (ANO). ANO blocks 
translation of VACV early mRNAs, without affecting cellular protein synthesis (Kane & 
Shuman, 1995). 
Firstly, the effect of ANO on the synthesis of VACV C7, an early viral protein, was 
tested. Prior to infection THP-1 cells and MVA were pre-incubated with ANO for four 
and one hour, respectively. This led to a reduction of VACV C7 protein levels by 70% 
as compared to non-treated  MVA-infected THP-1 cells. The residual VACV-C7 
protein detected by WB is probably caused by the viral inoculum. (Fig. 2A,B). As 
expected, ANO blocked the transcription of the late viral gene VACV B15R but not 
the transcription of the early viral gene VACV E3L or the housekeeping gene GAPDH 
(Fig. 2C,D). As determined by RT-PCR, ANO increased the levels of cytokine 
mRNAs of IFN-β and CCL2 in MVA-infected THP-1 cells (Fig. 2C,D). CCL2 and 
CXCL8 protein production was strongly upregulated in the presence of ANO in MVA-
infected THP-1 cells (Fig. 2E). Interestingly, the secretion of CCL2 was induced in 
VACV WR-infected THP-1 cells in the presence of ANO (Fig. 2E). These results 
indicates that early viral protein synthesis rather inhibits than induces cytokine 
expression in THP-1 cells.   
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Fig.2. MVA-induced cytokines in THP-1 infected cells is independent of viral early 
protein translation. THP-1 cells were infected with MVA or VACV WR at an MOI of 4. 
Where indicated cells were pretreated with ANO at concentrations as indicated. (A) Cells 
were lysed 6 h p.i. and protein was analyzed with a VACV C7L specific Western Blot. 
GAPDH was used to demonstrate equal protein loading. Where indicated (*), protein 
extraction was performed at 0 h p.i. (B) Ratio of the VACV C7L protein band intensity to 
GAPDH. (C) Total RNA was isolated 6 h p.i. and analyzed using specific RT-PCRs as 
indicated. (D) Ratio of viral gene and cytokine band intensities to GAPDH. (E) Protein 
concentrations of CCL2 and CXCL8 was determined in the cellular supernatants by ELISA 
24 h. p.i. The data shown are representative of two independent experiments. Errors bars 
indicate SD.  
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4.1.3 MVA and VACV-Wyeth treated with limited dosages (0.2-0.8 J) of UV 
induce cytokine expression in the human monocytic cell line THP-1 and BMDM. 
The previous results indicate that the critical signal for induction of cytokine 
expression triggered by the virus is before viral protein translation starts.  
Therefore, the importance of viral nucleic acids for triggering cytokine production was 
investigated in THP-1 cells and BMDM. MVA and VACV were irradiated with different 
dosages of UV light, a method commonly used for blocking viral nucleic acid 
synthesis. Firstly the dosage of UV light used to irradiate MVA and its affects on 
replication were determined. As shown in figure 3, MVA irradiated with UV-light at 0.8 
and 3.2 J was unable to productively replicate in BHK21 cells, which is permissive for 
MVA replication (Fig. 3).  
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Fig.3. UV-treated MVA does not replicate in BHK21 cells. (A) To measure virus 
replication, BHK21 cells were infected with MVA or UV-treated MVA at an MOI of 0.05. Virus 
titers were determined by TCID50 at the indicated time points.  
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Furthermore, even a dosage of 0.2 J was sufficient to nearly completely prevent early 
viral protein synthesis in THP-1 cells (Fig. 4C,D) and BMDM (Fig. 5C,D). In contrast, 
a dosage higher than 0.8 J was necessary to prevent detection of early viral RNA by 
RT-PCR in THP-1 cells (Fig. 4A,B), however in BMDM (Fig. 5A,B), even a dosage of 
1.6 J was not sufficient. 
When the dosage of UV was sufficient (1.6 J) to reduce viral mRNA to a level where 
it was no longer detectable by RT-PCR, CCL2, CXCL8 and IFN-β mRNA were 
reduced to the levels of mock-infected THP-1 cells (Fig. 4A,B). Of note, treatment of 
MVA with UV light at 0.2 J and 0.4 J led to enhanced induction of chemokines in 
THP-1 cells (Fig. 4A,B,E).  
In BMDM, treatment of MVA with UV light at a dosage of 0.2 J was sufficient to 
prevent detection of the late VACV B15R mRNA by RT-PCR. In contrast, even if 
MVA was treated with UV light at a dosage of 1.6 J the early VACV E3L mRNA as 
well as cytokines were still detected. 
CCL2 and TNF-α protein concentrations were increased in supernatants of BMDM 
infected with MVA treated with UV light at a dosage of 0.2 J and 0.4 J as compared 
to supernatants of BMDM infected with non-treated MVA (Fig. 5E). 
The wild type strains VACV Wyeth and VACV WR did not trigger cytokine expression 
in THP-1 cells and BMDM, respectively. However, interestingly, when VACV was 
treated with UV light at low dosages (0.2-0.8) then it gained the ability to elicit 
cytokine production in THP-1 cells (Fig. 4E) and BMDM (Fig. 5E).  
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Fig.4. Effect of UV light on MVA and VACV Wyeth induced cytokine expression in THP-
1 cells. THP-1 cells were infected with MVA or VACV Wyeth at an MOI of 4. Viruses were 
irradiated with UV light at dosages as indicated. (A) Total RNA was isolated 6 h p.i. and 
analyzed using specific RT-PCR. (B) Ratios of VACV E3L and cytokine band intensities to 
GAPDH band intensities. (C)  Cells were lysed 6 h p.i. and analyzed with a VACV E3L 
specific Western Blot. GAPDH was used to demonstrate equal protein loading. (D) Ratios of 
VACV E3L protein band intensities to GAPDH protein band inensities. (E) CCL2 and CXCL8 
protein concentrations were determined by ELISA in the cellular supernatants collected 24 h 
p.i. The data shown are representative of two independent experiments. Errors bars indicate 
SD.  
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Fig.5. MVA and VACV WR treated with UV light induce cytokine expression in BMDM. 
BMDM were infected) with MVA and VACV WR, at an MOI of 1.  Viruses were irradiated with 
UV light at dosages as indicated. (A) Total RNA was isolated 6 h p.i. and analyzed using 
specific RT-PCR. (B) Ratios of VACV E3L and cytokine band intensities to GAPDH band 
intensities.  (C)  Cells were lysed 6 h p.i. and analyzed by a VACV E3L specific WB. GAPDH 
was used to demonstrate equal protein loading. (D) Ratios of VACV E3L protein band 
intensities to GAPDH protein band intensities.  (E) CCL2 and TNF-α protein concentration 
were determined by ELISA in the cellular supernatants collected 24 h p.i. The data shown 
are representative of two independent experiments. Errors bars indicate SD.  
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4.1.4 Toll-like receptor 2 and 4 do not mediate MVA induced CCL2 and IFN-β 
expression in BMDM. 
Previously, a role for TLR2 in sensing VACV has been proposed (Barbalat et al, 
2009; O'Gorman et al, 2010; Zhao et al, 2009; Zhu et al, 2007). Therefore, the 
capability of MVA to induce cytokine expression in TLR2/TLR4-deficient (TLR2-/-
/TLR4-/-) BMDM was investigated.  
First, wild type BMDM were infected with MVA or stimulated with P3CSK4 or LPS 
which are ligands for TLR2 and TLR4, respectively. RT-PCR revealed that MVA, 
P3CSK4 and LPS increased CCL2 mRNA to nearly equal levels in wild type BMDM. 
IFN-β mRNA was only induced by MVA (Fig. 6A,B). As expected, P3CSK4 and LPS 
did not increase CCL2 mRNA levels in TLR2-/-/TLR4-/- BMDM. Importantly, MVA 
increased mRNA levels of CCL2 and IFN-β as compared to the levels detected in 
cells challenged with P3CSK4 and LPS (Fig. 6C,D). As shown in wild type BMDM 
(Fig. 5), VACV treated with UV light gained the capability to elicit cytokine production 
in TLR2-/-/TLR4-/- BMDM (Fig. 6C,D). Additionally, treatment of MVA and VACV with 
UV light until a dosage of 0.8 J did not prevent early viral mRNA and cytokine mRNA 
detection by RT-PCR (Fig. 6 C,D). Thus, TLR2 and TLR4 play no role in MVA 
induced cytokine expression in BMDM.  
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Fig.6. Effect of UV light on MVA and VACV Wyeth increased CCL2 and IFN-β mRNA 
levels in TLR2-/-/TLR4-/- BMDM. BMDM from wild type and TLR2-/-/TLR4-/- mice were 
infected with MVA or VACV Wyeth at an MOI of 1 or challenged with P3CSK4 (1 µg/ml) or 
LPS (1 µg/ml). Viruses were irradiated with UV light at dosages as indicated. (A) Total RNA 
from wild type BMDM and (C) TLR2-/-/TLR4-/- BMDM were isolated 6 h p.i. and analyzed 
using specific RT-PCR. (B, D) Ratios of VACV E3L and cytokine band intensities to GAPDH 
band intensities.  
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4.1.5 MVA heated at 55°C does not affect cytokine expression in MVA-infected 
THP-1 cells and BMDM. 
The previous results indicate that the presence of early viral mRNA correlates with 
the capability of MVA and VACV, which was treated with UV light, to induce cytokine 
expression. Since it cannot be excluded that treatment with high dosages of UV light 
has additional affects beyond the inhibition of  viral mRNA transcription, viruses were 
also treated with heat which prevents detection of viral mRNA by RT-PCR in infected 
cells while preserving the integrity of some functional proteins in the viral particle 
(Harper et al, 1978). Heat-treatment of VACV at 55°C for 1 h selectively affects the 
activity of the viral capping enzyme which is present in the virion and required for 
termination of viral transcription (Broyles, 2003). 
Treatment of MVA at 55°C for 1 h or at 75°C for 20 min abrogated its replication in 
the permissive cell line BHK21 (Fig. 7) and completely blocked early viral protein 
synthesis in THP-1 cells (Fig. 8B) and BMDM (Fig. 9B). 
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Fig.7. Heat treated MVA does not replicate in BHK21 cells. BHK21 cells were infected 
with MVA at an MOI of 0.05. Where indicated, MVA was treated at 55°C or 75°C for 1 h or 20 
min, respectively. Virus titers were determined by TCID50 at the indicated time points.  
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As expected, heating of MVA at 75°C for 20 min completely blocked its capability to 
trigger cytokine mRNA transcription (Fig. 8A and Fig. 9A). However, heat treatment 
of MVA at 55°C for 1 h did not affect its capability to induce cytokine mRNA synthesis 
and protein production in THP-1 cells (Fig. 8A,C,D) and BMDM (Fig. 9A,C,D).  
Furthermore, it was confirmed that VACV WR does not induce cytokine production in 
THP-1 cells (Fig. 8C,D) and BMDM (Fig. 9C,D). However, CCL2 expression was 
strongly enhanced in BMDM infected either with MVA or VACV WR heated at 55°C 
for 1 h (Fig. 9C,D).  
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Fig.8. MVA heated at 55°C for 1 h induces cytokine expression in THP-1 cells. THP-1 
cells were infected with MVA at an MOI of 4. (A) Total RNA was isolated 6 h p.i. and 
analyzed using specific RT-PCR as indicated. (B)  Cells were lysed 6 h p.i. and analyzed 
with a VACV C7L specific Western Blot. GAPDH was used to demonstrate equal protein 
loading. (C) CCL2 and (D) CXCL8 protein concentration in the cellular supernatants collected 
24 h p.i. were determined by ELISA. The data shown are representative of two independent 
experiments. Errors bars indicate SD. 
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Fig.9. MVA heated at 55°C for 1 h induces cytokine expression in BMDM. BMDM were 
infected with MVA at an MOI of 1 (A) Total RNA was isolated 6 h p.i. and analyzed using 
specific RT-PCR. (B) Cells were lysed 6 h p.i. and analyzed with a VACV C7L specific 
Western Blot. GAPDH was used to demonstrate equal protein loading. (C) CCL2 and (D) 
TNF-α protein concentration in the cellular supernatants collected 24 h p.i. were determined 
by ELISA. The data shown are representative of two independent experiments. Errors bars 
indicate SD.  
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4.2 Type I interferon receptor (IFNAR) is involved in CCL2 expression of MVA-
infected BMDM.  
4.2.1 Kinetic analysis of cytokine expression in MVA-infected BMDM. 
To study the temporal sequence of viral and cytokine mRNA induction in MVA 
infected BMDM, a kinetic analysis was performed. The expression of the 
housekeeping gene GAPDH was used as control and the levels of each RNA 
investigated were determined always also in mock-infected cells.  
Early viral gene expression as indicated by VACV E3L transcripts was detected at 1 
h p.i. while late gene transcription as indicated by VACV B15R RNA was detected at 
3 h p.i., which further increased until 8 h p.i. (Fig. 10 A,C). This represents the typical 
temporal pattern of VACV transcription. IFN-β expression was detected already at 2 
h p.i, preceding chemokine expression (Fig. 10 A,C). Up-regulation of CCL2 and 
CXCL10 mRNA by MVA was detected as early as 4 h p.i. (Fig. 10 A,C).  
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Fig.10. MVA-infection profile in macrophages. (A) BMDM were infected with MVA at an 
MOI of 1, total RNA was isolated after infection at times as indicated and analyzed using 
specific RT-PCR. (B) Ratio of viral and (C) cytokine PCR product intensities towards GAPDH 
PCR product intensity.  
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4.2.2 MVA-induced CCL2 expression in BMDM is modulated by IFNAR  
TNF-α and type I IFNs induce CCL2 expression (Conrady et al, 2013; Sung et al, 
2002), yet the kinetic analysis of cytokine expression in MVA-infected BMDM 
indicated that the activation of IFN-β mRNA transcription but not of TNF-α mRNA 
precedes the induction of CCL2. Taken together, type I IFNs constitute potential 
candidates that may induce CCL2 in MVA-infected BMDM. Therefore, the role of the 
type I interferon receptor (IFNAR) for CCL2 expression was tested using BMDM from 
mice deficient for this receptor (IFNAR-/-). TNF-α and IFN-β mRNA but no CCL2 
mRNA were induced in MVA-infected BMDM from IFNAR-/- mice, and the level was 
dependent on the MOI applied (Fig. 11). The lack of CCL2 expression was confirmed 
at the protein level by ELISA in MVA infected BMDM from IFNAR-/- mice (Fig. 11E). 
This indicates that IFNAR is involved in MVA induced CCL2 expression in BMDM. 
In contrast, the level of TNF-α expression was similar in MVA-infected BMDM of wild 
type and IFNAR-/- mice (Fig. 11F). The TLR2 agonist P3CSK4 induced CCL2 as well 
as TNF-α transcription and protein production in both MVA-infected BMDM of wild 
type and IFNAR-/- mice (Fig. 11E,F).  
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Fig.11. MVA-induced CCL2 expression depends on IFNAR. (A) BMDM from C57BL/6 
(WT) and (B) IFNAR-/- mice were infected with MVA at an MOI of 1. Total RNA was isolated 
at 6 h p.i. and analyzed using specific RT-PCR. (C) CCL2 and (D) TNF-α concentration in the 
cellular supernatants of BMDM collected 24 h p.i. were determined by ELISA. The data 
shown are representative of three independent experiments. Errors bars indicate SD.  
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4.3 O-GlcNacylation is involved in the induction of CCL2 expression in MVA-
infected cells. 
The promoters of many inflammatory cytokines are controlled by the transcription 
factor NF-κB (Sung et al, 2002), and NF-κB is activated by MVA (Martin & Shisler, 
2009). The activity of NF-κB is modulated by reversible attachment of N-acetyl-
glucosamine (O-GlcNAc) on the hydroxyl group of serine and threonine (Golks et al, 
2007). The O-GlcNAcylation pattern of intracellular proteins in MVA-infected THP-1 
cells was different to non-infected cells (Fig. 12A). Therefore, the requirement of O-
GlcNAcylation for induction of CCL2 production in MVA-infected THP-1 cells was 
investigated. The analysis was done in presence of the O-GlcNAcase (OGA) 
inhibitors glutamine and O-(2-Acetamido-2-deoxy-D-glucopyranosylidene) amino N-
phenyl carbamate (PUGNAC), which prevent removal of O-GlcNAc on the proteins. 
The GlcNAc residue is attached to proteins by O-linked N-acetylglucosamine 
transferase (OGT) (Hart et al, 2011), and alloxan is an inhibitor of OGT (Lee et al, 
2006). Therefore, modulation of CCL2 expression in MVA-infected cells by alloxan 
treatment was investigated. Indeed, alloxan decreased CCL2 production in MVA-
infected THP-1 cells in a dose dependent manner (Fig. 12B).  
As Lehmann et al. have shown that the MVA-induced CCL2 expression in THP-1 
cells promotes the migration of monocytes and macrophages (Lehmann et al, 2009) 
the relevance of O-GlcNAcylation in MVA-infected THP-1 cells for inducing cell 
migration of naïve THP-1 cells was investigated. As shown in figure 12C, migration of 
naïve THP-1 cells towards supernatants of MVA-infected THP-1 cells treated with 
alloxan was decreased as compared to supernatants from non-treated, naïve THP-1 
cells.  
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Fig.12. O-GlcNAcylation is required for MVA-induced chemokine expression in THP-1 
cells. (A) THP-1 cells were infected with MVA and incubated in the presence or absence of 
glutamine and PUGNAC as indicated. Cells were lysed 8 h p.i. and analysed Western Blot.. 
Actin was used to demonstrate equal protein loading. (B) CCL2 concentration in the cellular 
supernatants of THP-1 cells collected 24 h p.i. were determined by ELISA. Errors bars 
indicate SD (C) Number of THP-1 cells that migrated towards cell culture supernatants of 
mock or MVA-infected THP-1 cells in the presence or absence of alloxan. Data are means ± 
SEM, (n ≥ 3). *,P< 0.05.  
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5. DISCUSSION 
In the last years several recombinant VACV have been designed as viral vectors to 
produce vaccines against a broad number of infectious diseases (Gilbert, 2013). As a 
consequence, interest in understanding the interaction of VACV with the immune 
system has been renewed. The highly attenuated MVA is one of the most promising 
poxviral vectors, particularly because it is able to induce rapid local immune 
responses that might enhance its efficacy as a vaccine (Cottingham & Carroll, 2013; 
Gilbert, 2013; Price et al, 2013). Although the improved ability of MVA versus VACV 
in triggering immunogenic signaling is well known, the mechanisms of sensing MVA 
are not totally characterized. Therefore this study attempted to better understand how 
MVA triggers intracellular signaling. 
Since VACV is a DNA virus, the contribution of viral DNA replication for inducing 
cytokine expression in a monocytic cell line was evaluated. Inhibition of viral DNA 
replication did not decrease MVA-induced cytokine production in THP-1 cells. This 
result is in line with that obtained by Waibler et al., who reported that blocking viral 
DNA replication with AraC did not decrease the secretion of IFN-α in MVA-infected 
bone marrow plasmacytoid dendritic cells (BM-pDC) (Waibler et al, 2007). In 
contrast, it was reported that exposure of MVA-ΔE3L-infected keratinocytes to AraC 
at concentrations sufficient to block virus replication also abrogated IFN-β, IL-6, 
CCL4 and CCL5 production (Deng et al, 2008). Thus, it must be considered that the 
sensing of the virus is different in these cell types. Recently, several DNA sensors for 
VACV infection have been described (Yoneyama & Fujita, 2010b). Specifically, the 
adaptor molecule stimulator of interferon genes (STING) and the newly discovered 
DNA sensor cyclic GMP-AMP synthase (cGAS) seem to play a key role in the 
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recognition of viral DNA in VACV-infected cells (Ablasser et al, 2013). Furthermore, 
Dai et al. found that MVA induction of type I IFN was totally dependent on STING and 
cGAS, and in agreement with our results the induction of IFN in BMDC was 
independent of viral DNA replication (Dai et al, 2014). Another mechanism of sensing 
cytosolic viral DNA is mediated by RNA polymerase III, enzyme that synthesizes 
5´ppp RNA and induces type I IFN through the RIG-I and MAVS pathway (Chiu et al, 
2009).  
Previously it was proposed that early VACV proteins activate NF-κB, a key 
transcription factor necessary for expression of many inflammatory cytokines (Martin 
& Shisler, 2009). Therefore, early viral protein production was blocked by addition of 
ANO in VACV-infected cells and the effect on cytokine expression was investigated. 
The drug ANO substitutes ATP during RNA synthesis by viral RNA polymerase and 
blocks translation of viral proteins, without affecting cellular protein synthesis (Kane & 
Shuman, 1995). In the present study, synthesis of the early viral protein C7 was 
reduced more than 70% in the presence of ANO as compared with non-treated MVA-
infected cells. Previously,  it was reported that ANO completely prevents early VACV 
protein production as detected by [35S]methionine pulse-labeling, which can only 
detect de novo synthesized polypeptides (Kane & Shuman, 1995). In this study 
detection of viral protein was done by WB enabling detection of viral proteins which 
are also present in the virus preparation, as demonstrated by VACV C7. 
Importantly, cytokine secretion was enhanced in MVA and VACV WR-infected THP-1 
cells which were treated with ANO. This finding also confirms the previous 
observation that MVA-induced cytokine expression was independent of DNA 
replication, since early viral protein synthesis is required for the release of the viral 
genome prior to DNA replication (Mercer et al, 2012). In contrast, Martin and Shisler  
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claimed that early viral protein synthesis is necessary for NF-κB activation in MVA-
infected 293T fibroblast cells (Martin & Shisler, 2009). However, in that study 
cordycepin was used to block early viral protein synthesis, and cordycepin has been 
reported to exert many other effects such as (i) blocking of NF-κB activation (Lee et 
al, 2009), (ii) inhibition of reactive oxygen species production  (Won et al, 2009), (iii) 
increase of cyclic AMP and cyclic GMP concentration (Cho-HJ 2007 Eur. J 
Pharmacol) and (iv) induction of the anti-inflammatory cytokine IL-10 (Zhou et al, 
2002).  
Also UV light can be used to inactivate VACV, most probably by blocking viral nucleic 
acid production, though formation of thymidine dimers, with minimal effects on viral 
surface proteins (Tsung et al, 1996). In order to explore the contribution of viral 
nucleic acids to cytokine induction, VACV was irradiated with UV light at different 
dosages. The current study shows that MVA treated with high dosages of UV light (4 
J) does not induce cytokine production in MVA-infected THP-1 cells and MVA-
infected BMDM. These results are similar to a previous study, which showed that 
treatment of MVA with UV light for 20 min prevented CCL2 secretion in vitro and in 
vivo (Lehmann et al, 2009). On the other hand, chemokine production was enhanced 
in cells infected with MVA or VACV treated with low dosages of UV light (0.25-0.8 J), 
which is in line with the findings that MVA irradiated with low dosages of UV light 
enhanced IFN-α response in BM-pDC and BM-mDC (Waibler et al, 2007). 
Additionally, Drillien et al. observed that irradiated MVA is still able to activate human 
DC, measured by the up-regulation of the activation marker CD86 (Drillien et al, 
2004). The current study demonstrates that enhanced cytokine production correlates 
with the synthesis of early viral mRNA. Previously, it has been shown that UV 
treatment of VACV for two minutes results in inactivation of viral replication without 
affecting early viral transcription (Tsung et al, 1996), which is in agreement with the 
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present findings that low dosages of UV (0.25-0.8 J) do not affect early viral 
transcription, but prevent early viral protein translation and consequently viral 
replication. Therefore, a few crosslinks in the large genome of VACV might inhibit 
viral replication without affecting viral early mRNA transcription that occurs inside the 
core.  
VACV encodes a myriad of proteins involved in host evasion, and many of them 
inhibit signaling pathways that lead to the production of IFNs and cytokines in the 
infected cells (Seet et al, 2003). Previously it has been reported that the capability of 
VACV to block IFN-α production is conferred mainly by early viral proteins (Waibler et 
al, 2009). Thus, inhibition of early viral protein expression, while preserving early 
mRNA transcription might be one reason for enhanced cytokine production by cells 
infected with VACV treated with low dosages of UV, since the virus may have lost 
immunomodulatory proteins able to block the innate immune response. Another fact 
to be considered is that VACV irradiated with high dosages of UV light is still able to 
enter the cell (Tsung et al, 1996). Thus, only the fusion of the VACV virion with the 
cell surface and entrance to the cytosol seem to be not sufficient to trigger cytokine 
expression, in contrast with the report about herpes simplex virus (HSV)-1, in which 
virus-cell fusion was sufficient for triggering innate immunity in a STING-dependent 
manner (Holm et al, 2012). On the other hand, it would be interesting to test whether 
MVA or VACV irradiated with low dosages of UV are still able to protect mice against 
a lethal challenge with mousepox or VACV WR. 
The present study raised concerns that the use of UV-inactivated VACV could lead to 
false interpretations, regarding TLR2-mediated cytokine secretion, when the 
experiments are not suitably controlled. Particularly, UV-treatment of VACV has been 
used to claim the relevance of TLR2 for sensing VACV infection (Barbalat et al, 
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2009). However, most of these studies have not checked for possible residual gene 
transcription, which could potentially be involved in triggering cytokine expression.  
In order to test the relevance of TLR2 in mediating the enhanced cytokine production 
induced by irradiated VACV, BMDM from TLR2-/-/TLR4-/- mice were infected. There 
was no difference in cytokine production from wild type BMDM and TLR2-/-/TLR4-/- 
BMDM infected with MVA irradiated with UV. This finding indicates that the enhanced 
cytokine production was independent of the presence of TLR2 and TLR4. While some 
studies have claimed the importance of TLR2 for sensing VACV, other groups could 
not confirm this hypothesis (Davies et al, 2014; Zhao et al, 2009). TLR2 has been 
typically associated with bacteria ligands, and reports showing their relevance as viral 
sensors in VACV infection are highly contradictory. Thus, as it was mentioned above, 
there is concern that some of those results are due to contaminations that could 
potentially lead to false interpretations (Davies et al, 2014; Price et al, 2013).  
To further investigate which viral components are important for inducing cytokine 
expression in MVA-infected cells, MVA and VACV were heated at 55°C for one hour 
or at 75°C for 20 min prior to infection. Harper et al. determined that heating of VACV 
at 55°C for one hour damaged the capping enzyme that is required for transcription 
termination (Harper et al, 1978). These authors showed that RNA transcripts 
synthesized in vitro by heat-treated virions were longer, suggesting a defect in 
termination of transcription, whilst also being uncapped and partially double-stranded 
(Harper et al, 1978). The authors proposed that these uncapped and aberrant mRNA 
were unlikely to be translated into proteins (Harper et al, 1978), which is in 
agreement with the present finding. Additionally they also could not detect mRNA 
transcription in cells infected with VACV heated at 55°C, possibly because the 
uncapped mRNA was degraded too fast. Also, the mRNA transcription was checked 
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one hour p.i in the current study, assuming that perhaps the mRNA were degraded 
too fast. Moreover, at that time it was not possible to detect viral mRNA. On the other 
hand, Cao et al. detected that GFP expression under an early viral promoter was 
significantly reduced in human plasmacytoid dendritic cells infected with heated-
VACV-GFP at 55°C for one hour  (Cao et al, 2012). Similarly, in the current study it 
was confirmed that early viral protein expression was completely abrogated in VACV-
infected cells, when the virus was heated at 55°C for 1 hr or at 75°C for 20 min. 
Otherwise, Dai et al. proposed that heated-VACV (55°C, 1 hr) induces cytokine 
production in murine keratinocytes, and that this induction is dependent on sensing 
cytosolic viral dsRNA (Deng et al, 2008). Similarly, Cao et al. demonstrated that 
VACV heated at 55°C for one hour induced IFN-I production in pDCs which requires 
activation of endosomal TLR7 and its adaptor MyD88 (Cao et al, 2012). In contrast, 
Drillien et al. suggested that binding or uptake of heated-VACV (55°C) was sufficient 
to activate DC (Drillien et al, 2004).   
VACV WR only induced cytokine production in BMDM, when the virus was heated at 
55°C for one hour. This observation coincides with those of Cao et al., who found 
that VACV heated to 55°C for one hour induces pDCs to produce IFN-α and TNF-α 
(Cao et al, 2012). In another study it was shown that after incubating VACV at 55°C 
for 1 hr the virus was still capable of activating human monocyte-derived 
conventional DC (Drillien et al, 2004). However, when MVA was treated at 75°C for 
20 minutes the cytokine production in THP-1 cells and BMDM was completely 
abolished. In agreement, it has been reported that heating MVA at 75°C for 20 
minutes prevented CCL2 protein secretion (Lehmann et al, 2009). Additionally, 
heating VACV at 65°C for one hour or 100°C for 5 minutes abolished cytokine 
induction (Cao et al, 2012). Also differences in the virus preparation it would 
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modulate the sensitivity of the virus to the heating process, fact that influences the 
results obtained for the differents groups  
Taken together, these findings indicate that in MVA-infected macrophages cytokine 
induction is independent of early viral protein synthesis, viral DNA replication and 
viral intermediate/late mRNA transcription. Thus, any viral component, maybe early 
viral mRNA synthesis or genomic DNA, during the early phase of the virus replication 
cycle, is sufficient to induce cytokine production in MVA-infected macrophages. 
Similarly, Lynch et al. concluded that early events in the viral replication cycle, prior to 
early protein synthesis and DNA replication were sufficient to promote IκBα 
degradation in MVA-infected cells (Lynch et al, 2009). Furthermore, the same study 
showed that MVA activates PKR-mediated signaling pathways even in the absence 
of DNA replication, suggesting that early events may constitute the first stimuli to 
PKR activation. Indeed, they and others have demonstrated that viral dsRNA from 
early transcripts possess PKR activating function (Lynch et al, 2009; Willis et al, 
2011). Particularly, with respect to viral mRNA, several studies reported the 
importance of RNA sensors for detecting VACV infection (Delaloye et al, 2009; Deng 
et al, 2008; Guerra et al, 2007).  
Curiously, when early viral protein synthesis is inhibited in VACV Wyeth or VACV 
WR, the virus gained the capability to induce cytokine production. This fact suggests 
that VACV possess the intrinsic capacity to trigger cytokine secretion, which is 
blocked by immunomodulatory proteins expressed by the virus. Many of these viral 
proteins that are capable of blocking cellular signaling pathways are expressed 
during the early phase of the viral replication cycle. Interestingly, when the 
expression of early viral proteins in MVA is affected, the induction of cytokines is 
enhanced, suggesting that MVA still carries some genes that are able to inhibit 
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cellular activation. Therefore, in theory, it should be possible to further improve the 
immune stimulatory capacity of MVA. Alternatively, in the absence of early protein 
synthesis there is a continuous early viral mRNA transcription that may induce 
cytokine expression more potently than in normal conditions.  
Previously Lehmann et al. have shown that MVA triggered the migration of 
leukocytes into the lungs of infected mice, in contrast to other VACV strains 
(Lehmann et al, 2009). MVA upregulated the expression of CCL2, CCL3, CXCL8 and 
CXCL10 in an intranasal infection model of VACV, and it was demonstrated that 
CCL2 plays a key role in the early immigration of leukocytes into the lung (Lehmann 
et al, 2009). Moreover, it was found that MVA induces the expression of the 
chemotactic factor CCL2 in THP-1 cells. Similar results were obtained in human 
macrophages, in which MVA induced the production of large quantities of 
chemokines (CCL2, CCL4, CCL5, CXCL8 and CXCL10) (Delaloye et al, 2009) while 
only small amounts of pro-inflammatory cytokines such as: TNF-α, IL-1α, IL-1β and 
IL-6 (Delaloye et al, 2009).  
It has been shown that IFNAR stimulation leads to the induction of CCL2 expression 
(Conrady et al, 2013) Thus, the contribution of IFNAR to MVA-induced chemokine 
expression in macrophages was investigated. The infection of BMDM from IFNAR-/- 
mice with MVA demonstrated that signaling through IFNAR plays a crucial role in the 
induction of CCL2 expression in murine macrophages. Previously it has been 
reported that systemic release of IFN during MCMV infection drives expression of 
CCL2 in bone marrow cells, which induces monocyte migration to the site of infection 
(Crane et al, 2009). Also, the relevance of IFNs for mediating migration and cytotoxic 
activity of NK cells which are important for controlling MCMV infection has been 
reported (Orange & Biron, 1996). In a murine infection model of MCMV, IFN-α/β 
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promoted CCL2 production and plays a distinctive role in the recruitment of 
macrophages (Hokeness et al, 2005). Moreover, IFN signaling has been linked to 
VACV specific CD8+ lymphocyte expansion and activation (Quigley et al, 2008). 
Additionally in the current study it was found that IFN-β mRNA synthesis in MVA-
infected IFNAR-/- BMDM was lower than in wild type BMDM, suggesting that the 
positive feedback loop via IFNAR was relevant for the expression of IFN-β, which is 
in line with a previous report concerning IFN-α production in pBMDC (Waibler et al, 
2007).  
Inflammatory cytokine and type I IFN expression is partially mediated via the 
activation of the transcription factor NF-κB, which regulates the promoters of many of 
these genes (Sung et al, 2002). The activity of NF-κB is modulated by O-
GlcNAcylation, and it has been shown that this posttranslational modification of NF-
kB is required for full activation of some cells of the immune system (Golks & Guerini, 
2008). Thus this study investigated whether O-GlcNAcylation is important for 
triggering CCL2 expression in MVA-infected macrophages. Firstly it was found that 
the O-GlcNAcylation pattern of intracellular proteins in MVA-infected THP-1 cells is 
different compared to non-infected cells, suggesting that MVA infection alters the 
normal O-GlcNAcylation levels of the host cells. The O-GlcNAcylation pattern of 
intracellular proteins in MVA-infected THP-1 cells was similar to VACV WR-infected 
THP-1 cells. Western Blot alone may not be sensitive enough to detect O-GlcNAc 
modification on specific proteins. Therefore, future studies are necessary to 
determine whether there are differences in the O-GlcNAcylation pattern of specific 
intracellular signalling proteins in MVA or VACV-infected cells.  
Blocking O-GlcNacylation with alloxan leads to decreased expression of CCL2 in 
MVA-infected THP-1 cells. This suggests that O-GlcNacylation is necessary for MVA 
triggered cytokine expression in monocytes, perhaps due to the O-GcNAc 
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modification of key transcriptions factors like NF-κB. In line with these results, it was 
reported that chemokine production was regulated by O-GlcNAcylation of nuclear 
proteins in a monocytic cell line  (Chikanishi et al, 2010). Previously, it was shown 
that full activation of T and B lymphocytes mediated by TCR and BCR, respectively, 
requires O-GlcNAcylation of NF-κB (Golks et al, 2007). Moreover, O-GlcNAcylation 
seems to modulate chemotaxis of monocytes induced by MVA-infected THP-1 cells, 
since CCL2 is one of the main chemotactic factor secreted by MVA-infected 
monocytes.  
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6. SUMMARY 
The highly attenuated poxvirus strain MVA is a very promising viral vector vaccine 
candidate against a broad spectrum of infectious diseases. Despite the lack of 
productive viral replication in most mammalian cells, MVA is highly immunogenic. 
The mechanism how MVA triggers the innate immune response is not well 
understood. Thus, the first objective of this study was to investigate which 
components of VACV play major roles in triggering cellular signaling pathways, 
leading to the expression of inflammatory cytokines in monocytes/macrophages. It 
was shown that MVA-induced cytokine expression was independent of viral DNA 
replication and early viral protein synthesis in human monocytic THP-1 cells. 
Treatment of MVA with a dosage of UV light that allows transcription of early but not 
intermediate or late viral RNA did not affect its capability to induce interferon-β (IFN-
β) and chemokine expression in THP-1 cells and bone marrow-derived macrophages 
(BMDM). In contrast to other VACVs, MVA induces cytokine expression in infected 
macrophages; however when the replication competent VACV strains Wyeth and 
Western Reserve (WR) were treated with low doses (0.1-0.8 J) of UV light they also 
gained the capability to induce cytokine production in THP-1 cells and BMDM. Using 
BMDM deficient for Toll-like receptors 2 (TLR2) and TLR4 it was shown that these 
receptors play no role in MVA induced cytokine expression. Overall, these results 
indicate that viral components sensed during an early phase of the viral replication 
cycle, most likely early viral mRNAs and/or genomic DNAs are sufficient to trigger 
cytokine expression in MVA-infected macrophages. 
To further explore the mechanisms of chemokine induction in MVA-infected BMDM, 
the involvement of type I interferon receptor (IFNAR) in the modulation of chemokine 
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(C-C motif) ligand 2 (CCL2) expression was tested. The results indicate that CCL2 
expression in MVA-infected BMDM is induced in an IFNAR-dependent manner.  
Furthermore, the importance of posttranslational modification by O-GlcNacylation in 
MVA induced chemokine expression was investigated. O-GlcNacylation of 
intracellular proteins in MVA-infected THP-1 cells was different as compared to non-
infected cells, suggesting that MVA infection alters the normal O-GlcNacylation levels 
of the host cells. Additionally, it was shown that blocking O-GlcNacylation decreases 
the expression of CCL2 in MVA-infected THP-1 cells. This data suggests that MVA-
induced O-GlcNacylation is relevant for MVA-triggered CCL2 expression. 
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7. ZUSAMMENFASSUNG 
Das hoch attenuierte Modifizierte Vaccinia Virus Ankara (MVA) ist ein 
vielversprechender Virusvektor-Impfstoffkandidat gegen ein breites Spektrum von 
Infektionskrankheiten. Obwohl sich MVA in den meisten Säugetierzellen nicht 
produktiv vermehrt, ist es hoch immunogen. Bisher ist wenig zu den Mechanismen 
bei der Auslösung einer angeborenen Immunantwort nach MVA-Infektion bekannt. 
Ein Ziel dieser Studie war es herauszufinden, welche viralen Komponenten zur 
primären Stimulierung zellulärer Signalkaskaden beitragen und somit zur Expression 
inflammatorischer Zytokine in Monozyten bzw. Makrophagen führen. Für humane 
monozytäre THP-1-Zellen wurde gezeigt, dass die MVA-induzierte Zytokinexpression 
unabhängig von der viralen DNA-Replikation und der Synthese früher viraler Proteine 
ist. Die Fähigkeit von THP-1-Zellen und Knochenmarksmakrophagen zur Interferon- 
β (IFN-β)- und Chemokinexpression wurde durch eine UV-Behandlung von MVA mit 
Strahlungsdosen, die nur noch die Transkription früher, viraler RNA erlaubt, nicht 
beeinträchtigt. Im Gegensatz zu anderen Vacciniaviren induziert MVA die 
Zytokinexpression in infizierten Makrophagen. Jedoch führte auch die Behandlung 
der replikationsfähigen Vacciniavirusstämme Wyeth und Western Reserve (WR) mit 
niedrigen UV-Strahlungsdosen (0.1-0.8 J) zur Zytokinproduktionsinduktion in THP-1-
Zellen und Kochenmarksmakrophagen. Die Toll-Like-Rezeptoren (TLR)-2 und -4  
spielen keine Rolle bei der MVA-induzierten Zytokinexpression, was nach der 
Infektion von Knochenmarksmakrophagen, die diese Rezeptoren nicht aufwiesen, 
gezeigt werden konnte. 
 Insgesamt deuten diese Ergebnisse darauf hin, dass bereits erste virale Signale im 
Replikationszyclus der Viren, höchstwahrscheinlich frühe virale mRNA und/ oder 
genomische DNA, für die Auslösung der Zytokinexpression in MVA-infizierten 
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Makrophagen ausreichen. Weiter wurde getestet, ob der Typ-1-Interferon-Rezeptor 
(IFNAR) die Expression des Chemokin (C-C-Motiv) Liganden-2 (CCL2) moduliert. 
Die Ergebnisse weisen auf eine IFNAR-abhängige Induktion der CCL-2-Expression 
in MVA-infizierten Knochenmarksmakrophagen hin. Schließlich wurde auch die 
Relevanz der posttranslationalen O-GlcNAc-Modifikation bei der MVA-induzierten 
Chemokinexpression untersucht. Die O-GlcNAc-Modifikation von intrazellulären 
Proteinen in MVA-infizierten THP-1-Zellen unterschied sich von der in nicht-infizierten 
Zellen, was eine Veränderung der normalen O-GlcNAc-Modifikation in der Wirtszelle 
durch eine MVA-Infektion annehmen lässt. Zusätzlich wurde gezeigt, dass die CCL2-
Expression in MVA-infizierten THP-1-Zellen über eine Hemmung der O-GlcNAc-
Modifikation reduziert werden kann. Diese Ergebnisse sprechen für die Relevanz der 
MVA-induzierten O-GlcNAc-Modifikation bei der durch MVA ausgelösten CCL2-
Expression. 
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8. ABBREVIATIONS 
β-ME              β-mercaptoethanol 
ADAR adenosine deaminase acting on RNA  
Amp ampicillin 
ANO adenosine N1-oxide 
APS ammonium persulfate 
APC  antigen presenting cells 
AraC cytosine arabinoside 
ATP      adenosine triphosphate 
bp     base pairs 
BSA bovine serum albumin 
BMDM bone marrow-derived macrophages 
BM-pDC bone marrow plasmacytoid dendritic cells  
CCL2 chemokine (C-C motif) ligand 2 
cDNA complementary DNA 
CD4 cluster of differentiation 4 
CD8 cluster of differentiation 8 
CEF  chicken embryo fibroblast 
CEV cell associated enveloped virus 
cGAS DNA sensor cyclic GMP-AMP synthase 
CMV   cytomegalovirus 
CTL CD8 cytotoxic lymphocyte 
CVA  chorioallantois vaccinia virus Ankara 
CXCL8  chemokine (C-X-C motif) ligand 8 
CXCL10 chemokine (C-X-C motif) ligand 10 
DC  dendritic cells 
DMEM dulbecco`s Modified Eagle Medium 
DNA desoxyribonucleic acid 
dNTP desoxyribonucleotide triphosphate 
dsDNA double stranded DNA 
DTT dithiotreitol 
ECTV ectromelia virus  
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EEV extracellular enveloped viron 
ER endoplasmic reticulum 
ECL enhanced chemiluminescence 
EDTA ethylenediamine tetraacetic acid 
EF1α elongation factor 1α 
FACS fluorescence activated cell sorting 
FCS fetal calf sera 
GAGs glycosaminoglycans 
GAPDH glycerinaldehyd-3-Phosphat-dehydrogenase 
GFP green fluorescent protein 
GlcN glucosamine 
GM-CSF  granulocyte Macrophage colony stimulating factor 
HeLa cervix carcinoma cell line isolated from Henrietta Lacks 
HRP horseradish peroxidase 
HSV  herpes simplex virus 
IEV  intracellular enveloped virus 
IFNAR type I IFN receptor 
IFN-I type I interferon 
IFN-β interferon-β 
IMV   intracellular mature viron 
ISG IFN stimulated genes 
IgG immunoglobulin G 
IL interleukin 
LPS lipopolysaccharides 
MAVS mitochondrial antiviral signaling proteins  
MCMV  murine cytomegalovirus 
MDA5 melanoma differentiation associated gene 5 
MHCI major histocompatibility complex class I 
MOI  multiplicitiy of infection 
MPV monkeypox virus 
mRNA messenger RNA 
MVA modified vaccinia virus Ankara 
Myd88 myeloid differentiation primary response gene 88  
NCOAT nuclear and cytoplasmic O-GlcNAcase and histone 
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acetyltransferase 
ncOGT nucleocytoplasmic OGT 
NFAT nuclear factor of activated T cells 
NF-κB        nuclear factor-kappa B 
NK  natural killer cells 
nt nucleotide 
OAS 2'-5'-oligoadenylate synthetase 
OD optical density 
O-GlcNAc O-liked N-Acetyl-D-Glucosamine 
O-GlcNAcase O-GlcNAc hexosaminidase 
OGT O-GlcNAc transferase 
ORF open reading frames 
P3CSK4 synthetic lipopeptide N-palmitoyl-S-[2,3-bis(palmitoyloxy)-  
(2R,S)-propyl]-(R)-cysteinyl-seryl-(lysyl)3-lysine 
PAGE polyacrylamide gel electrophoresis 
PAMPs  pathogen associated molecular patterns 
PKR protein Kinase R 
PMN polymorphonuclear leukocytes 
PRR Pathogen recognition receptors 
PBS phosphate buffered saline  
PCR polymerase chain reaction 
RNA ribonucleic acid 
RLR RIG-I-like receptor 
RT room temperature / reverse transcriptase 
ROS  reactive oxygen species 
SDS sodium dodecyl sulfate 
ssRNA single stranded RNA 
STING stimulator of interferon genes 
TEMED N, N, N´, N´-tetramethylethylenediamine 
TLR  toll-like receptor 
TNF-α tumor necrosis factor alfa 
TRIF TIR-domain-containing adapter-inducing interferon-β 
UV ultraviolet 
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VACV vaccinia virus 
VACV WR Western Reserve 
VLE very low endotoxin 
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